Katie Carillon
Medical · Maumelle, ARNPI 1649538679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by GSK at 35.7% of the total. Reporting peaked in 2021 at $261 and has fallen 54.7% since, to $118 in 2025.
Across 48 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$288
- Amgen$106
- AbbVie$40
- Silk Road Medical, Inc.$37
- Amarin Pharma, Inc.$35
- Boston Scientific$34
- plus $267 from 13 others
What the payments were for
- Food & beverage$807100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $288 |
| Amgen | 6 | $106 |
| AbbVie | 2 | $40 |
| Silk Road Medical, Inc. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $35 |
| Boston Scientific | 1 | $34 |
| Sanofi Pasteur Inc. | 2 | $34 |
| AstraZeneca | 2 | $33 |
| Novo Nordisk | 2 | $28 |
| Abbott | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Nevro Corp. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$807 in reported general payments places this provider in the 55th percentile of 133 medical providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 16 | $402 |
| Cefdinir | 19 | $206 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $192 |
| Metformin Hcl | 17 | $85 |
| Mupirocin | 15 | $79 |
| Diclofenac Sodium | 12 | $57 |
| Prednisone | 19 | $53 |
Paid to pharmacies, not to this prescriber.
Other medical in Maumelle
- Matthew ReynoldsRussellville$207K
- Tara BrunerSearcy$16K
- Dallas BondhusHot Springs$15K
- Douglas ClarkLittle Rock$14K
- Alexandra SanromaLittle Rock$11K
- Caleb MasonSearcy$9K
- Katherine McCradyLittle Rock$9K
- Bailey PollockLittle Rock$9K
- Hannah BreauLittle Rock$9K
- Thurman SmithFayetteville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.